Acorda Therapeutics Inc - Company Profile
Powered by
All the data and insights you need on Acorda Therapeutics Inc in one report.
- Save hours of research time and resources with
our up-to-date Acorda Therapeutics Inc Strategy Report
- Understand Acorda Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Acorda Therapeutics Inc (Acorda), is a biopharmaceutical company that discovers, develops, and markets therapies for people with neurological disorders. Focused R&D activities, marketed product: Inbrija, and proprietary technology are its strengths even as the declining performance of Ampyra and operating loss position could be causes for concern for the company. Acorda could benefit from its pipeline products, and market potential: pain and growing US healthcare industry. However, government regulations and intense competition could hamper the company's growth prospects.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer